Cargando…
Early HER2-positive breast cancer arising from a fibroadenoma: a case report
Breast cancer arising from fibroadenoma (FA) is rare, in which almost all reported cases are human epidermal growth factor receptor 2 (HER2)-negative. This is the first report to describe a case of HER2-positive breast cancer arising from FA that was treated with chemotherapy plus anti-HER2 therapy....
Autores principales: | Fujimoto, Akihiro, Matsuura, Kazuo, Kawasaki, Tomonori, Ichinose, Yuki, Nukui, Asami, Hiratsuka, Miyuki, Asano, Aya, Shimada, Hiroko, Osaki, Akihiko, Saeki, Toshiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436269/ https://www.ncbi.nlm.nih.gov/pubmed/34527256 http://dx.doi.org/10.1093/omcr/omab083 |
Ejemplares similares
-
Granuloma after breast conserving surgery—a report of three cases
por: Ichinose, Yuki, et al.
Publicado: (2021) -
Tumor budding and fibrotic focus—proposed grading system for tumor budding in invasive carcinoma no special type of the breast
por: Hiratsuka, Miyuki, et al.
Publicado: (2022) -
Carney complex with multiple breast tumours including breast cancer: a case report
por: Fujimoto, Akihiro, et al.
Publicado: (2022) -
High grade angiosarcoma arising in fibroadenoma
por: Babarović, Emina, et al.
Publicado: (2011) -
Neoadjuvant chemotherapy with trastuzumab, docetaxel, and carboplatin administered every 3 weeks for Japanese women with HER2-positive primary breast cancer: efficacy and safety
por: Sugitani, Ikuko, et al.
Publicado: (2017)